RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Acta Pharmaceuticals

Acta Pharmaceuticals

Acta Pharmaceuticals focused on developing new therapies for early intervention and prevention of Alzheimer's disease.

Latest funding

$24M Seed ·

Source: citybiz.co

Funding history ↓
LinkedIn: linkedin.com.
Sectors: Biotechnology, Manufacturing, Pharmaceutical.
Stage: Seed.
Based in: Boston, United States.
Last round: Oct 15, 2026 · 8 days ago.
Domain age: 4 years.
On Recent Funding since: Oct 16, 2026.
About Acta Pharmaceuticals

Acta Pharmaceuticals is a company based in Boston, United States. Recent Funding lists it under Health and bio (also Manufacturing and industrial). It raised $24M in a Seed round in October 2026, according to citybiz.co. Investors on record include Alzheimer's Research Foundation, Dolby Family Ventures and Gamma Biosciences. It was founded by Rudolph E. Tanzi.

Funding rounds

  1. Seed · $24M
    Source: citybiz.co
  2. Website created

Founders and team

Investors

Similar Health and bio companies

Questions and sources

Acta Pharmaceuticals: questions and answers

How much has Acta Pharmaceuticals raised?
Acta Pharmaceuticals has raised $24M in one sourced round on record (Seed), announced October 15, 2026.
Who invested in Acta Pharmaceuticals?
Investors on record for Acta Pharmaceuticals: Alzheimer's Research Foundation, Dolby Family Ventures and Gamma Biosciences.
Who founded Acta Pharmaceuticals?
Acta Pharmaceuticals was founded by Rudolph E. Tanzi (Scientific Founder).
Where is Acta Pharmaceuticals based?
Acta Pharmaceuticals is based in Boston, United States.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/acta-pharmaceuticals (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy